Chrome Extension
WeChat Mini Program
Use on ChatGLM

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, As a Single Agent in Patients with Advanced Solid Tumors

The Oncologist(2024)

Cited 2|Views2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined